There is continuing local and regional need for high-quality and broadly affordable tools and medicines to effectively diagnose and treat several diseases with high prevalence in Africa’s rapidly emerging ‘frontier’ markets and other endemic regions.

Fyodor is focusing its initial efforts on the developing novel tools for the management of clinical malaria and currently has two products in development:

1. Urine Malaria Test (UMT) – a rapid test for the diagnosis of clinical malaria from urine that can be used by untrained persons
2. Yeast-derived Artemisinin – a novel approach to the production of artemisinin in yeast, an antimalarial drug compound with increasingly broader therapeutic applications in cancer and hepatitis